BNTX
- Market
BioNTech stock sinks more than 8% after profit, revenue fall below expectations
The U.S.-listed shares of Germany-based BioNTech SE BNTX, +1.48% sank 8.2% in premarket trading Monday, after the biotechnology company and…
Read More » - Market
Official U.S. tally of new cases may be declining, but at-home testing obscures data; Novavax opens trial of vaccine for very young children
The daily average of new U.S. cases may have started to decline based on official numbers, but it’s unclear at…
Read More » - Market
Novavax’s protein-based vaccine approval fails to boost stock as demand in U.S. for shots and boosters remains low
U.S. health regulators authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option that works differently than the two…
Read More » - Market
New omicron variant worries experts as it spreads in India, and Moderna says new booster offers better protection against BA.4 and BA.5
A new, highly infectious subvariant of omicron is raising concerns among scientists and health experts as it spreads in India…
Read More » - Market
WHO head slams ‘scandalous inequity’ in COVID vaccines with 10 countries accounting for 75% of doses administered
The head of the World Health Organization slammed wealthy countries for a “scandalous inequity” in COVID-19 vaccines that is prolonging…
Read More » - Market
India records more than 200,000 COVID cases for seventh straight day as hospitals run low on oxygen
The global tally of confirmed cases of the coronavirus-borne illness COVID-19 climbed above 143 million on Wednesday, as India reported…
Read More » - Market
U.S. COVID deaths top 500,000 as experts look to FDA meeting on J&J’s one-dose vaccine
The U.S. surpassed half a million deaths from the coronavirus-borne illness COVID-19 on Monday, as experts braced for a Food…
Read More »
